Loading...
Images of Terufumi Kato
(0 from 0 )1
0
0
News
Aktuelle Ergebnisse der Krebsforschung am WTZ | Lungenkrebszentrum am...
www.lwtz.de
... Vera Hirsh, Tony Mok, Sarayut Lucien Geater, Sergey Orlov, Chun-Ming Tsai, Michael Boyer, Wu-Chou Su, Jaafar Bennouna, Terufumi Kato, Vera Gorbunova, ...
Telephone & Addresses
Erlotinib Plus Bevacizumab Phase ll Study in Patients with Advanced...
ideas.repec.org
Terufumi Kato & Takashi Seto & Makoto Nishio & Koichi Goto & Noboru Yamamoto & Isamu Okamoto & Liang Tao & Wei Yu & Tarik Khaznadar & Kosei Tajima ...
Network Profiles
LinkedIn: Terufumi Kato - LinkedIn
LinkedInは、Terufumi Katoさんのような方が活動する世界最大のプロフェッショナルネットワークです。今すぐあなたも参加してビジネスの人脈や知識を広げましょう。
Interests
Respiratory Medicine - Vol n° 9 - EM consulte
www.em-consulte.com
Ryo Okuda, Eri Hagiwara, Tomohisa Baba, Hideya Kitamura, Terufumi Kato, Takashi Ogura. fleche fermer Résumé fleche fermer Résumé fleche ouvert ...
Business Profiles
Researchgate: Terufumi Kato
Yokohama, Japan
Books & Literature
IASLC | International Association for the Study of Lung Cancer
library.iaslc.org
Welcome to the International Association for the Study of Lung Cancer
Terufumi Kato | XanEdu Customization Platform
www.academicpub.com
Author: Terufumi Kato. Results. EGFR mutation in various tissues Springer Science+Business Media By: Terufumi Kato; Hideyuki Yokote; ...
authors:"Terufumi Kato" - Search | Paperity
paperity.org
Paperity: the 1st multidisciplinary aggregator of Open Access journals & papers. Free fulltext PDF articles from hundreds of disciplines, all in one place
A prospective, multicentre phase II trial of low-dose erlotinib in...
www.infona.pl
Kazuhiko Yamada, Hiromi Aono, Yukio Hosomi, Hiroaki Okamoto, Terufumi Kato, Yuko Komase, Masanori Nishikawa, Koichi Azuma, …
Related Documents
Tratamiento del NSCLC basado en alteraciones moleculares
www.slideshare.net
Selección terapéutica con biomarcador
CiteSeerX — Lung Cancer
citeseerx.ist.psu.edu
@MISC{Sekine06lungcancer, author = {Ikuo Sekine and Minako Sumi and Yoshinori Ito and Terufumi Kato and Yasuhito Fujisaka and Hiroshi Nokihara and Noboru …
Efficacy and Safety of Combined Carboplatin, Paclitaxel, and...
ar.iiarjournals.org
... TOMOHISA BABA,; HARUYASU MURAKAMI,; KIYOTAKA YOH,; TAKASHI OGURA,; TOSHIAKI TAKAHASHI,; KOICHI GOTO and; TERUFUMI KATO. + Author ...
EBSCOhost | | Quality of Life with Gefitinib in Patients...
web.a.ebscohost.com
SHOJI OKINAGA,j TERUFUMI KATO,k TOSHIYUKI HARADA,l AKIHIKO GEMMA,m YASUO SAIJO,n. YUKI YOKOMIZO,b SATOSHI MORITA,o KOICHI ...
Scientific Publications
Client Request Error
www.sciencedirect.com
The online version of The Lancet Oncology at ScienceDirect.com, the world's leading platform for high quality peer-reviewed full-text journals.
Phase III study of afatinib or cisplatin plus pemetrexed in patients...
pubmed.ncbi.nlm.nih.gov
PubMed comprises more than 30 million citations for biomedical literature from MEDLINE, life science journals, and online books. Citations may include links to...
Feasibility study of first-line chemotherapy using Pemetrexed and...
bmccancer.biomedcentral.com
BMC Cancer BMC Cancer main menu. About; Articles; Submission Guidelines; Research article Terufumi Kato 3, Shingo Miyamoto 4, Kentaro Sakamaki 5, Tetsu Shinkai
Promising effect of chemotherapy with bevacizumab for patients with...
www.sciencedirect.com
... Medicine, Kanagawa Cardiovascular and Respiratory Center, Tomioka-higashi, Kanazawa-ku, Yokohama , Japan. email. ,. Terufumi Kato.
Publications
Publications Authored by Terufumi Kato | PubFacts
www.pubfacts.com
Publications Authored by Terufumi Kato
Pemetrexed and carboplatin followed by pemetrexed maintenance therapy...
link.springer.com
Introduction This study prospectively evaluated the efficacy and safety of pemetrexed and carboplatin followed by maintenance pemetrexed in chemo-naïv
Terufumi Kato's Research | CureHunter
www.curehunter.com
Terufumi Kato Selected Research. Terufumi Kato Research Topics. Disease. 8, Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
Dr. Sarayut L. Geater, MD - Prince of Songkla University - Dr. |...
www.pubfacts.com
Dr. Sarayut L. Geater is a board-certified pulmonologist, and has been working as a lecturer in the Faculty of Medicine, Prince of Songkla University, since...
Reports & Statements
[ASCO 2014] Câncer de Pulmão - Manual de Oncologia Clínica do Brasil
mocbrasil.com
Author(s): Terufumi Kato, Takashi Seto, Makoto Nishio, et al. Open-label randomized trial. Patients with stage 3b/4 or recurrent non-squamous ...
Miscellaneous
Terufumi Kato | LinkedIn
www.linkedin.com
View Terufumi Kato’s professional profile on LinkedIn. LinkedIn is the world's largest business network, helping professionals like Terufumi Kato discover inside ...
Combinations for Treating EGFR Acquired Resistance - ppt video...
slideplayer.com
Combination Treatments for EGFR Acquired Resistance Dx: EGFR+ lung cancer Acquired Resistance Tarceva Tarceva + NEW DRUG Gilotrif Key issue for combination...
BooKsc Proxy Mirror - Terufumi Kato: free download. Ebooks library ...
booksc.bypassed.eu
Terufumi Kato: free download. Ebooks library. On-line books store on Z-Library | BookSC. Download books for free. Find books.
Using Non-targeted Therapies in Targeted Lung Cancer Populations...
slideplayer.com
Why would anyone use chemotherapy in an EGFR mutant or ALK+ lung cancer patient? 3
Researcher: Terufumi Kato in Publications - Dimensions
app.dimensions.ai
Satoshi Ikeda, Terufumi Kato, Takashi Ogura, Akimasa Sekine, Tsuneyuki Oda, Noriyuki Masuda, Satoshi Igawa, Ken Katono, Sakiko Otani, Kouzo Yamada, ...
Terufumi Kato
www.infona.pl
Kazuto Nishio, Tokuzo Arao, Terufumi Kato, Hideyuki Yokote · Cancer Chemotherapy and Pharmacology 58 , 1 , Somatic ...
Terufumi Kato | Admin Project Alpha
admin.alpha.intstrux.com
Quality of Life with Gefitinib in Patients with EGFR-Mutated Non-Small Cell Lung Cancer: Quality of Life Analysis of North East Japan Study ...
Unexpectedly high incidence of pneumothorax in patients with ...
erj.ersjournals.com
Baba, Ryuichi Nishihira, Shigeru Komatsu, Terufumi Kato, Takashi Ogura.
Altmetric – Phase III Study of Afatinib or Cisplatin Plus Pemetrexed...
www.altmetric.com
... Vera Hirsh, Tony Mok, Sarayut Lucien Geater, Sergey Orlov, Chun-Ming Tsai, Michael Boyer, Wu-Chou Su, Jaafar Bennouna, Terufumi Kato, Vera Gorbunova, ...
Afatinib verlengt progressie vrije overleving bij patiënten met...
kanker-actueel.nl
... Sarayut Lucien Geater, Sergey V Orlov, Chun-Ming Tsai, Michael J. Boyer, Wu-Chou Su, Jaafar Bennouna, Terufumi Kato, Vera Gorbunova, Ki Hyeong Lee, ...
Bevacizumab Added to Erlotinib Increases PFS in NSCLC | Cancer Network
www.cancernetwork.com
... and perhaps increase efficacy of erlotinib, said Terufumi Kato, MD, of the Kanagawa Cardiovascular and Respiratory Center in Yokohama, ...
Carboplatin-paclitaxel/nab-paclitaxel with or without pembrolizumab...
oncologypro.esmo.org
Presenter, Terufumi Kato. Citation, Annals of Oncology (2018) 29 (suppl_9): ix150-ix annonc/mdy425. Authors, T. Kato1, S. Lee2, ...
Never-smoking history as a poor prognostic factor in surgically...
erj.ersjournals.com
Tomohisa Baba, Yasunori Enomoto, Atsuto Nakazawa, Hideya Kitamura, Tsuneyuki Oda, Norikazu Matsuo, Terufumi Kato, Eri Hagiwara, Koji Okudera, Tae Iwasawa, ...
Erlotinib Plus Bevacizumab Phase ll Study in Patients with Advanced...
kyushu-u.pure.elsevier.com
Terufumi Kato, Takashi Seto, Makoto Nishio, Koichi Goto, Noboru Yamamoto, Isamu Okamoto, Liang Tao, Wei Yu, Tarik Khaznadar, Kosei ...
Volume 37 Issue 3 | Japanese Journal of Clinical Oncology | Oxford...
academic.oup.com
JAPANESE JOURNAL OF CLINICAL ONCOLOGY ... Terufumi Kato, Yasuhito Fujisaka, Hiroshi Nokihara, Noboru Yamamoto, Hideo Kunitoh, Yuichiro Ohe and …
Osimertinib versus standard-of-care EGFR-TKI as …
academic.oup.com
· Terufumi Kato. Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Kanazawa-ku, Yokohama, Japan Search for other works by this ...
Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients...
hwmaint.jco.ascopubs.org
... Nobuyuki Yamamoto, Shizuoka Cancer Center, Shizuoka; Terufumi Kato, Kanagawa Cardiovascular and Respiratory Center, Yokohama, Japan; Kenneth O'Byrne, St …
Phase I Study of Cisplatin Analogue Nedaplatin, Paclitaxel, and...
academic.oup.com
AbstractBackground. The standard treatment of unresectable stage III non-small cell lung cancer is concurrent chemoradiotherapy in patients in good general cond
Antibiotic resistance genotype trend and association with host...
erj.ersjournals.com
... Nakazawa, Akimasa Sekine, Hideya Kitamura, Tomohisa Baba, Takeshi Shinohara, Ryuichi Nishihira, Shigeru Komatsu, Terufumi Kato, Takashi Ogura.
Boehringer Ingelheim presents strong lung cancer portfolio and...
kommunikasjon.ntb.no
Terufumi Kato, Katsuyuki Kiura, Carlos H Barrios, Martin Schuler, Vera Hirsh, Nobuyuki Yamamoto, Kenneth O'Byrne, Tony Mok, Dan Massey ...
sorted by relevance / date